Video

Beyond Full-Empty Capsids: Additional AAV Quality Concerns & Questions To Address

Source: Cytiva

In this segment, Andrew Tustian, the senior director of preclinical manufacturing and process development for Regeneron, and Justin Horvath, senior director of external manufacturing and manufacturing sciences for Regenxbio, identify additional impurities beyond full-empty capsids — as well as other analytical development exercises — deserving of greater industry attention.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Cytiva